MediciNova (NASDAQ:MNOV) Raised to "Hold" at Zacks Research
Zacks Research raised MediciNova to a "hold" rating in a research note on Tuesday...
MarketBeat·3d ago
More News
Q1 Earnings Estimate for MediciNova Issued By HC Wainwright
MediciNova, Inc. (NASDAQ:MNOV - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for MediciNova in a research report issued on Monday, March 16th...
MarketBeat·4d ago
MediciNova (NASDAQ:MNOV) Now Covered by HC Wainwright
HC Wainwright initiated coverage on shares of MediciNova in a research note on Monday. They issued a "buy" rating and a $10.00 price target on the stock...
MarketBeat·6d ago
MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving Average - Should You Sell?
MediciNova (NASDAQ:MNOV) Stock Passes Above 200 Day Moving Average - Should You Sell...
MarketBeat·16d ago
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have earned an average rating of "Moderate Buy" from the five brokerages that are presently covering the company, MarketBeat reports. One...
MediciNova (NASDAQ:MNOV - Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.05) EPS for the quarter, beating the consensus estimate of...
MarketBeat·30d ago
MediciNova, Inc. (NASDAQ:MNOV) Short Interest Update
MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) was the target of a large drop in short interest in January. As of January 30th, there was short interest totaling 225,373 shares, a drop of 16.7...
MarketBeat·1mo ago
MediciNova (MNOV) Projected to Post Earnings on Wednesday
MediciNova (NASDAQ:MNOV) will be releasing earnings before the market opens on Wednesday, February 18. (View Earnings Report at...
MarketBeat·1mo ago
MediciNova (NASDAQ:MNOV) Shares Pass Above 200-Day Moving Average - Here's What Happened
MediciNova (NASDAQ:MNOV) Shares Pass Above 200-Day Moving Average - Here's What Happened...
MarketBeat·1mo ago
MediciNova's (MNOV) Buy Rating Reaffirmed at D. Boral Capital
D. Boral Capital reissued a "buy" rating and set a $9.00 price objective on shares of MediciNova in a research note on Friday...